Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

There are far too many avoidable deaths in childbirth

For Financial Times, the Foundations CEO, Jayasree K. Iyer, writes about access to sexual and reproductive health in resource-poor countries, and discusses what pharmaceutical companies and the global health community can do to prevent avoidable deaths of women and infants.

Date

18 January 2024

Direct links

Read the full op-ed

In 1934, Kaveri, a 19-year-old girl in Malaya, died of severe bleeding after giving birth to a baby boy. She was my grandmother. My father grew up motherless while my grandfather toiled round the clock in a rubber plantation.

Nearly a century later, the international community has committed to consigning such avoidable deaths to history. Yet progress has stalled, leaving vulnerable women and newborns around the world at the mercy of broken healthcare systems and without access to life-saving medicines.

The evidence is plain to see. A woman dies somewhere in the world every two minutes during pregnancy or childbirth, and each day more than 6,000 neonatal babies die within their first four weeks of life. This unacceptable death toll is especially high in sub-Saharan Africa.

But it doesn’t have to be this way. As of 2020, there were around 30 countries where maternal and newborn deaths were still falling, showing that progress is possible. However, mortality rates in the majority of resource-poor countries have stagnated or gone backwards. While the UN’s sustainable development goals set a target of no more than 70 maternal deaths per 100,000 live births by 2030, the global ratio remained three times above that level at 223 per 100,000 in 2020.

Read the full op-ed on the Financial Times website.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the media

Read other op-eds by Jayasree K. Iyer
Media

Op-ed: Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them

11 December 2023
Media

Op-ed: Farmaceuten moeten niet zo gefixeerd zijn op winsten

23 October 2023
Media

Sickle cell cures are coming. African children can’t be left behind

12 July 2023

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved